Intravenous Iron in Inflammatory Bowel Disease

Seminars in Hematology

Volumn 43, Issue SUPPL. 6, 2006, Pages

  Gasche, Christoph ^a   Kulnigg, Stefanie ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; ERYTHROPOIETIN; FERRIC HYDROXIDE SUCROSE; FERROUS SULFATE; IRON; MERCAPTOPURINE; MESALAZINE; SALAZOSULFAPYRIDINE;

ANAPHYLAXIS; ANEMIA; ARTICLE; BITTER TASTE; DIARRHEA; DISEASE EXACERBATION; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; ENTERITIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTENSION; INJECTION SITE PAIN; IRON DEFICIENCY; PREVALENCE; PRIORITY JOURNAL; SIDE EFFECT; SYMPTOM; ULCERATIVE COLITIS;

EID: 33749254836     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2006.08.010     Document Type: Article

References (54)

1. Cho J.H., Nicolae D.L., Gold L.H., Fields C.T., LaBuda M.C., Rohal P.M., et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: Evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A 95 (1998) 7502-7507
2. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
3. Gasche C., and Grundtner P. Genotypes and phenotypes in Crohn's disease: Do they help in clinical management?. Gut 54 (2005) 162-167
4. Dalziel T.K. Chronic interstitial enteritis. Br Med J 2 (1913) 1068
5. Moum B., and Ekbom A. Epidemiology of inflammatory bowel disease-Methodological considerations. Dig Liver Dis 34 (2002) 364-369
6. Blanchard J.F., Bernstein C.N., Wajda A., and Rawsthorne P. Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis. Am J Epidemiol 154 (2001) 328-335
7. Cosnes J., Carbonnel F., Beaugerie L., Le Quintrec Y., and Gendre J.P. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 110 (1996) 424-431
8. Sandborn W.J., Tremaine W.J., Offord K.P., Lawson G.M., Petersen B.T., Batts K.P., et al. Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 126 (1997) 364-371
9. Best W.R., Becktel J.M., Singleton J.W., and Kern F.J. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 70 (1976) 439-444
10. Truelove S.C., and Witts L.J. Cortisone in ulcerative colitis: Final report on a therapeutic trial. Br Med J 4947 (1955) 1041-1048
11. Gasche C. Anemia in IBD: The overlooked villain. Inflamm Bowel Dis 6 (2000) 142-150
12. Yates P., Macht L.M., Williams N.A., and Elson C.J. Red cell autoantibody production by colonic mononuclear cells from a patient with ulcerative colitis and autoimmune haemolytic anaemia. Br J Haematol 82 (1992) 753-756
13. Hansen T.M., Hansen N.E., Birgens H.S., Holund B., and Lorenzen I. Serum ferritin and the assessment of iron deficiency in rheumatoid arthritis. Scand J Rheumatol 12 (1983) 353-359
14. Weiss G., and Goodnough L.T. Anemia of chronic disease. N Engl J Med 352 (2005) 1011-1023
15. Gasche C., Reinisch W., Lochs H., Parsaei B., Bakos S., Wyatt J., et al. Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency. Dig Dis Sci 39 (1994) 1930-1934
16. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102 (2003) 783-788
17. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 (2004) 2090-2093
18. Babbs C.F. Oxygen radicals in ulcerative colitis. Free Radic Biol Med 13 (1992) 169-181
19. Erichsen K., Hausken T., Ulvik R.J., Svardal A., Berstad A., and Berge R.K. Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease. Scand J Gastroenterol 38 (2003) 543-548
20. De Silva A.D., Tsironi E., Feakins R.M., and Rampton D.S. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: A prospective, comparative trial. Aliment Pharmacol Ther 22 (2005) 1097-1105
21. Erichsen K., Milde A.M., Arslan G., Helgeland L., Gudbrandsen O.A., Ulvik R.J., et al. Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis. Inflamm Bowel Dis 11 (2005) 744-748
22. Oldenburg B., Berge Henegouwen G.P., Rennick D., Van Asbeck B.S., and Koningsberger J.C. Iron supplementation affects the production of pro-inflammatory cytokines in IL-10 deficient mice. Eur J Clin Invest 30 (2000) 505-510
23. Carrier J., Aghdassi E., Platt I., Cullen J., and Allard J.P. Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther 15 (2001) 1989-1999
24. Carrier J., Aghdassi E., Cullen J., and Allard J.P. Iron supplementation increases disease activity and vitamin E ameliorates the effect in rats with dextran sulfate sodium-induced colitis. J Nutr 132 (2002) 3146-3150
25. Carrier J.C., Aghdassi E., Jeejeebhoy K., and Allard J.P. Exacerbation of dextran sulfate sodium-induced colitis by dietary iron supplementation: role of NF-kappaB. Int J Colorectal Dis 21 (2006) 381-387
26. Gasche C., Lomer M.C., Cavill I., and Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut 53 (2004) 1190-1197
27. Schroder O., Schrott M., Blumenstein I., Jahnel J., Dignass A.U., and Stein J. A study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal bleeding. Z Gastroenterol 42 (2004) 663-667
28. Gasche C., Dejaco C., Waldhoer T., Tillinger W., Reinisch W., Fueger G.F., et al. Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. Ann Intern Med 126 (1997) 782-787
29. Gasche C., Dejaco C., Reinisch W., Tillinger W., Waldhoer T., Fueger G.F., et al. Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin. Digestion 60 (1999) 262-267
30. Bodemar G., Kechagias S., Almer S., and Danielson B.G. Treatment of anaemia in inflammatory bowel disease with iron sucrose. Scand J Gastroenterol 39 (2004) 454-458
31. Schroder O., Mickisch O., Seidler U., de Weerth A., Dignass A.U., Herfarth H., et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease-A randomized, controlled, open-label, multicenter study. Am J Gastroenterol 100 (2005) 2503-2509
32. Erichsen K., Ulvik R.J., Nysaeter G., Johansen J., Ostborg J., Berstad A., et al. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol 40 (2005) 1058-1065
33. Gasche C., Waldhoer T., Feichtenschlager T., Male C., Mayer A., Mittermaier C., and Petritsch W. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. Am J Gastroenterol 96 (2001) 2382-2387
34. Wells C.W., Lewis S., Barton J.R., and Corbett S. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 12 (2006) 123-130
35. Crawford J., Cella D., Cleeland C.S., Cremieux P.Y., Demetri G.D., Sarokhan B.J., et al. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer 95 (2002) 888-895
36. Vijverman A., Piront P., Belaiche J., and Louis E. Evolution of the prevalence and characteristics of anemia in inflammatory bowel diseases between 1993 nd 2003. Acta Gastroenterol Belg 69 (2006) 1-4
37. Ershler W.B., Chen K., Reyes E.B., and Dubois R. Economic burden of patients with anemia in selected diseases. Value Health 8 (2005) 629-638
38. Ebinger M., Leidl R., Thomas S., Von Tirpitz C., Reinshagen M., Adler G., et al. Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital. J Gastroenterol Hepatol 19 (2004) 192-199
39. Lakatos L., Pandur T., David G., Balogh Z., Kuronya P., Tollas A., et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: Results of a 25-year follow-up study. World J Gastroenterol 9 (2003) 2300-2307
40. Oldenburg B., Koningsberger J.C., Berge Henegouwen G.P., Van Asbeck B.S., and Marx J.J. Iron and inflammatory bowel disease. Aliment Pharmacol Ther 15 (2001) 429-438
41. Revel-Vilk S., Tamary H., Broide E., Zoldan M., Dinari G., Zahavi I., et al. Serum transferrin receptor in children and adolescents with inflammatory bowel disease. Eur J Pediatr 159 (2000) 585-589
42. Schreiber S., Howaldt S., Schnoor M., Nikolaus S., Bauditz J., Gasche C., et al. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med 334 (1996) 619-623
43. Horina J.H., Petritsch W., Schmid C.R., Reicht G., Wenzl H., Silly H., et al. Treatment of anemia in inflammatory bowel disease with recombinant human erythropoietin: Results in three patients. Gastroenterology 104 (1993) 1828-1831
44. Harries A.D., Fitzsimons E., Dew M.J., Heatley R.V., and Rhodes J. Association between iron deficiency anaemia and mid-arm circumference in Crohn's disease. Hum Nutr Clin Nutr 38 (1984) 47-53
45. Bambach C.P., and Hill G.L. Long term nutritional effects of extensive resection of the small intestine. Aust N Z J Surg 52 (1982) 500-506
46. Werlin S.L., and Grand R.J. Severe colitis in children and adolescents: diagnosis. Course, and treatment. Gastroenterology 73 (1977) 828-832
47. Reilly J., Ryan J.A., Strole W., and Fischer J.E. Hyperalimentation in inflammatory bowel disease. Am J Surg 131 (1976) 192-200
48. Reilly J., Ryan J.A., Strole W., and Fischer J.E. Hyperalimentation in inflammatory bowel disease. Am J Surg 131 (1976) 192-200
49. Greenstein A.J., Kark A.E., and Dreiling D.A. Crohn's disease of the colon. II. Controversial aspects of hemorrhage, anemia and rectal involvement in granulomatous disease involving the colon. Am J Gastroenterol 63 (1975) 40-48
50. Burbige E.J., Huang S.H., and Bayless T.M. Clinical manifestations of Crohn's disease in children and adolescents. Pediatrics 55 (1975) 866-871
51. Beeken W.L. Remediable defects in Crohn disease: A prospective study of 63 patients. Arch Intern Med 135 (1975) 686-690
52. Beeken W.L. Absorptive defects in young people with regional enteritis. Pediatrics 52 (1973) 69-74
53. Dyer N.H., Child J.A., Mollin D.L., and Dawson A.M. Anaemia in Crohn's disease. Q J Med 41 (1972) 419-436
54. Hoffbrand A.V., Stewart J.S., Booth C.C., and Mollin D.L. Folate deficiency in Crohn's disease: Incidence, pathogenesis, and treatment. Br Med J 597 (1968) 71-75